IPS101A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IPS101A, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients [Phase 1]